NCT06231303Not yet recruiting
Gut Microbiota Dysbiosis in Lupus Nephritis
Source: ClinicalTrials.gov · Last updated 30 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Evaluate dysbiosis of some intestinal microbiota in adult patients with lupus nephritis compared to healthy controls.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 20 Jan 2024
- Start date
- Jan 2025
- Primary completion date
- Jun 2026
- Lead sponsor
- Hager Zanaty
- Diseases
- Lupus (SLE)
- NCT number
- NCT06231303
What you commit to
- Study type: Observational
- Planned participants: 60
- From Jan 2025 to the primary completion date, Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects at age\<18 years. Diseases affecting the gut microbiota (e.g. chronic diarrhea, Crohn's disease, or ulcerative colitis).
- Patients on maintenance dialysis, with diabetes or pregnancy, using antibiotics, probiotics, prebiotics, or synbiotics in the previous 4 weeks.
- Patients with critical condition (hypertension emergency,urgency, acute myocardial infarction or stroke within the last 6 months) and suspected/confirmed renal vascular disease.
Who the study is looking for
- Adult male and female patients diagnosed with lupus nephritis. Adult age and sex matched healthy individuals will be included as a control group.
- Informed consent will be obtained from each study participant.
Age in the registry: 18 years to 50 years · Sex: Female
This page is information, not medical advice. Discuss any trial with your doctor.